Assessment of Neural Signals for the Control of Assistive Devices

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Miami

About this trial

The study will investigate the use of motor intention-based cortical signals to trigger epidural spinal cord stimulation (ESCS) with individuals with SCI. Motor intention of UL tasks will be decoded using brain-computer interface (BCI) system based on cortical signals recorded using an Electroencephalographic (EEG) system or using their intracranially implanted devices Electrocorticographic (ECoG).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients age 18 and older

Able to sign informed consent

Not participating in other studies that limit participation

Chronic (>6 month) traumatic Spinal Cord Injury (SCI) (C4-T1 neurological injury with American Spinal Injury Association Impairment Scale (AIS A-D) with some residual function.

Disqualifiers

Patients that are pregnant

Patients under the age of 18

Patients unable to provide informed consent

Trial design

Design model

Single group

Treatments tested in this trial

  • Epidural Spinal Cord Stimulation

    Procedure/Surgery

    This will be a one time surgery lasting no more than 2 hours where ESCS electrodes will be connected to an external stimulator approved for human research. Stimulation intensity and parameters will be configured before each session for optimal upper extremity motor function. The ESCS approach will include surgical implantation of temporarily placed leads in the cervical epidural space and connection cables tunneled percutaneously through the skin for \<30 days

  • Electrocorticographic

    Device

    Neural activity during upper and/or lower extremity tasks will be recorded to characterize the changes that occur in the signals before, during, and after task performance. Observed characteristics of neural signals that are related to the initiation, continuation, or termination of movement will be used to derive control signals that can trigger or enable assistive devices.

  • Electroencephalographic

    Device

    Neural activity during upper and/or lower extremity tasks will be recorded to characterize the changes that occur in the signals before, during, and after task performance. Observed characteristics of neural signals that are related to the initiation, continuation, or termination of movement will be used to derive control signals that can trigger or enable assistive devices.

Treatment groups

3 Participants
are divided into 1 treatment group
Group A: Brain Computer Interface-Epidural Spinal Cord Stimulation (BCI-ESCS)Experimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

Change in Hand Motor Function

Toronto Rehabilitation Institute Hand Function Test (TRI-HFT): Measured on a scale from 0-133 to assess upper extremity manipulation and grip force at time points before and after implant. Higher scores indicate better hand motor function.

Time frame
Baseline, up to 2 months post-implant
2

Change in Hand Motor Evoked Potential (MEP)

Change in Motor Evoked Potential (MEP): MEP evaluates corticospinal excitability (strength of the connections between the brain and the muscles). The excitability is measured as a peak-to-peak amplitude in millivolts (mV).

Time frame
Baseline, up to 2 months post-implant

Secondary outcomes

1

Change in Graded and Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP)

Graded and Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP): Standardized test to be measured on a scale from 0-116 through the combination of five subset scores to assess grasping ability at time points before and after implant. A composite score will be obtained for strength, muscle force and tasks. Higher scores indicate better hand motor function.

Time frame
Baseline, up to 2 months post-implant
2

Change in Muscle Coordination Measured by Electromyography (EMG)

Functional tasks: Assessments to measure reaching ability and obtain muscle coordination via EMG (millivolts).

Time frame
Baseline, up to 2 months post-implant
3

Change in Movement Kinematics

Kinematics data (motion capture, measured in centimeters) at time points before and after implant.

Time frame
Baseline, up to 2 months post-implant
4

Change in Muscle Strength

Muscle force testing: Assessment of changes in muscle strength from measured in Newtons at time points before and after implant.

Time frame
Baseline, up to 2 months post-implant

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.